Showing all 3 results

  • Placeholder
    In Stock

    Cefixime Dispersible Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Rapidly Disintegrating (DT) Matrix, packed in high-barrier Alu-Alu blister strips.

    Active IngredientStrengthPrimary Clinical Function
    Cefixime Trihydrate USP/Ph.Eur.100 mg / 200 mgThe Pediatric & Enteric Anchor: Dispersible format for easy administration in children and patients with dysphagia.
    ExcipientsSweetening & Flavoring AgentsCompliance Engineering: Formulated with high-grade fruit flavors and non-cariogenic sweeteners to mask the bitter antibiotic taste, ensuring 100% pediatric compliance.
    DisintegrantsSuper-Disintegrant BlendInstant-Dispersible Matrix: Engineered to shatter and form a smooth, grit-free suspension in < 45 seconds when placed in 5-10 mL of water.
  • Placeholder
    In Stock

    Cefixime Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the trihydrate salt.

    Active IngredientStrengthPrimary Clinical Function
    Cefixime (as Trihydrate) USP/Ph.Eur.200 mgThe Standard Primary Care Anchor: Utilized for uncomplicated UTIs, Otitis Media, and Pharyngitis.
    Cefixime (as Trihydrate) USP/Ph.Eur.400 mgThe Enteric & Gonorrhea Payload: High-efficacy therapeutic dose for Typhoid Fever and uncomplicated Gonorrhea.
    ExcipientsProprietary MatrixSolubility Enhancement: Engineered utilizing Laser Micronization of the API to ensure rapid dissolution and 100% bioequivalence to the innovator brand.
  • Placeholder
    In Stock

    Chlorthalidone Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the stability of the micronized active ingredient.

    Active IngredientStrengthPrimary Clinical Function
    Chlorthalidone USP/BP6.25 mg / 12.5 mgThe Contemporary Starting Dose: Highly preferred for modern “Low-Dose” hypertension therapy to maximize pressure control while minimizing electrolyte loss.
    Chlorthalidone USP/BP25 mgThe High-Potency Payload: Utilized for resistant hypertension or the management of edema associated with heart failure or hepatic cirrhosis.
    ExcipientsMicrocrystalline Cellulose / Colloidal Silicon Dioxide / Magnesium Stearate / Pregelatinized StarchDiluent / Glidant / Lubricant / Binder (Engineered specifically utilizing Micronized API Technology to ensure absolute uniformity in the 6.25mg and 12.5mg ultra-low-dose tablets, guaranteeing consistent renal response across every batch).